The directors of Amedica Corporation, a biomaterials company based in Salt Lake City, Utah, has named Jeff White to its board of directors. White is presently head of MedTech Advisory Group, LLC, a firm that advises mid-stage medical technology firms. Prior to founding MedTech, White served as global director of Business Development for Synthes, a multi-billion dollar global orthopedic firm that Johnson & Johnson acquired in 2013.
Amedica Names Jeff White to Board
1 min read Premium comments
White also co-founded two medical device companies including Applied Spine Technologies, Inc. where he led efforts to develop innovative spinal devices for patients suffering from spinal injuries or degeneration. He has held various positions with US Surgical Corporation and Richard Allan Medical Industries, Inc.
“We are fortunate to welcome Jeff as the newest addition to our board of directors, ” said Eric Olson, president and chief executive officer of Amedica Corporation. “His extensive background and experience in bringing novel technology solutions to market will help Amedica position itself for success as we look to enter new markets with our Silicon Nitride technology platform.”
Amedica is a privately owned company founded in 1996 that markets spinal fusion products and is developing other products for use in total hip and knee joint replacements.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.